Direct intragastric delivery of a diet, nutrient or test substance can be achieved in rodents (mice and rats) on a long-term (2-3 months) basis using a chronically implanted gastrostomy catheter and a flow-through swivel system. this rodent intragastric infusion (iG) model has broad applications in research on food intake, gastrointestinal (GI) physiology, GI neuroendocrinology, drug metabolism and toxicity, obesity and liver disease. It achieves maximal control over the rate and pattern of delivery and it can be combined with normal ad libitum feeding of solid diet if so desired. It may be adopted to achieve infusion at other sites of the GI system to test the role of a bypassed GI segment in neuroendocrine physiology, and its use in genetic mouse models facilitates the genetic analysis of a central question under investigation. intake spontaneously produces severe obesity, abdominal adiposity, hyperglycemia, hyperinsulinemia, hyperleptinemia, glucose tolerance, IR and NAFLD/NASH 25 . A model such as this would allow studies on interrelationships among these metabolic and pathologic phenotypes in their pathogenesis.
IntroDuctIon
iG model for the study of food intake and GI physiology Direct delivery of nutrients to stomach or intestine via an implanted catheter allows the testing of diverse and unique questions. These include the roles of a segment within the normal food intake route in neuroendocrine mechanisms of cephalic, GI and metabolic responses to nutrient intake [1] [2] [3] [4] [5] [6] [7] . Mechanisms of inhibition of gastric emptying or postgastric satiety are studied by using iG or intraduodenal infusion of a liquid diet in mice that have been given receptor antagonists for intestinal or pancreatic endocrine peptides such as cholecystokinin or amylin 8, 9 . The use of the iG model facilitates the identification of rapid postoral mechanisms of flavor preference conditioning by sugar and fat as well as its potential interaction with an orosensory response 3, 5 . The maintenance of a long-term access (2-3 months) to the GI tract is often challenging. However, if it is achieved, it enables the study of the physiologic or metabolic adaptation to and pathophysiological consequences of experimental dietary conditioning. Such approaches are becoming crucial to studies on physiologic and metabolic complications associated with lifestyle-related diseases such as metabolic syndrome associated with obesity as described below.
Modeling liver disease using the iG model
One of the early objectives for creation of the rodent long-term iG model was the scientific desire to test whether maximal ethanol intake results in major alcoholic liver disease (ALD) in rodents that are naturally averse to ethanol and otherwise do not voluntarily consume adequate amounts of ethanol to damage the liver. Answers derived from the model for this critical question were both yes and no. With a maximal intake of ethanol reaching as high as 49% of caloric intake facilitated by forced iG ethanol administration, the rat develops severe hepatic steatosis and elevated alanine aminotranferease (ALT) levels even with a diet low in fat, which does not cause these changes in the models with ad libitum consumption of ethanol-containing liquid diet 10 . An increase in the dietary content of polyunsaturated fat causes further progression to steatohepatitis 11 , and the addition of carbonyl iron 12 or enteral lipopolysaccharide administration 13 potentiates liver fibrosis. Thus, although maximal ethanol intake indeed causes more serious liver injury than that observed in other ad libitum models, it alone is not sufficient for progression of ALD. The development of the mouse iG model has revolutionized the field because it allows genetic studies of ALD. The iG model using mice deficient in tumor necrosis factor (TNF) receptor I, CD14, Toll-like receptor 4, LBP, p47phox, ICAM-1 and so on revealed the importance of endotoxin-mediated activation of hepatic macrophages, their NADPH oxidase activation and generation of reactive oxygen species, subsequent TNF-α induction and proinflammatory response in the ALD pathogenesis (see ref. 14 for a review).
Application to obesity-associated research
Another important application of the mouse iG model is obesityassociated metabolic syndrome including nonalcoholic fatty liver disease (NAFLD), which is recognized as a global epidemic and the most common type of liver disease 15 . Although NAFLD and more pathologically advanced nonalcoholic steatohepatitis (NASH) are associated with obesity-associated insulin resistance (IR), the precise pathogenetic relationship between them historically could not be studied because of the lack of animal models that reproduce the natural history and course of the disease in humans. Genetic models such as mice deficient in leptin 16 and leptin receptor 17 are not clinically relevant and do not develop steatohepatitis. Mice with targeted ablation of peroxisome proliferator-activated receptor-α (Ppara) 18 , acyl-CoA oxidase (Acox1) 19 , methionine adenosyltransferanse1A (Mat1a) 20 and phosphatase and tension homolog deleted on chromosome 10 (Pten) 21 all develop deranged liver metabolism and consequent NAFLD or/and NASH, but these mutations are, again, rare in patients. Feeding rodents a diet deficient in choline and methionine results in NASH 22 , but the model does not result in the development of obesity or IR, and this extreme malnutrition is not relevant to NAFLD and NASH in human patients. More natural nutrition models include feeding ad libitum a diet high in sucrose 23, 24 , fructose 23 or fat 24 . However, these models produce mild obesity and NAFLD but not NASH. The most common cause of obesity in humans is hypercaloric alimentation. The iG model can be used to reproduce this condition by forced feeding. Indeed, iG feeding of male C57BL/6 mice with high-fat diet at a level up to 85% in excess of the standard 6| Cut a piece of Dacron felt to a pear shape (8 mm width, 16 mm length) and pass the catheter through a hole made in the middle ('e' in Fig. 1a) ; next, glue it to the catheter angle with RTV silicone rubber resin and catalyst (Fig. 1c,d ).
7| Cut a Dacron felt disc (6 mm in diameter), pass the Silastic catheter tip via a hole made in the middle and glue the disc to Silastic tubing at a location 33 mm distal to the tip of the Tygon tubing ('g' in Fig. 1a) . 8| Place a 1-ml syringe with a 23-G Luer stub adaptor on the proximal end of the catheter (Fig. 1b) .
9| Gas-sterilize the catheter in a sterilization pouch before its use.  pause poInt The catheter can be presterilized and stored in a sealed pouch for 3-4 weeks.
surgical procedure • tIMInG 40 min maximum 10| Anesthetize a mouse (body weight 24-27 g) by intraperitoneal injection of ketamine (80 mg kg − 1 ) and xylazine (10 mg kg − 1 ). Ketamine and xylazine should be premixed and diluted with saline.  crItIcal step The surgery procedure should be complete in ~40 min or less. Anesthesia achieved by this regimen should sufficiently cover this duration.
11| Preparation of the mouse for aseptic surgery.
Clip the hair on the mid-abdomen and dorsal neck areas. Swab them with iodine solution and allow them to dry. Pull out the tongue and apply ointment on the mouse′s eyes. Wipe the surgical areas with 70% (vol/vol) ethanol. Place the mouse on a surgical table that has been covered with a sterile drape and heated with a water-circulating heating pad (set at 37 °C) placed underneath the drape to prevent hypothermia. Use sterile gauze to cover areas that have not been prepared. Fill a catheter with saline using a 1-ml syringe.  crItIcal step Sterilized surgical instruments, towels, gowns, catheter, gloves and sutures must be used.
12|
Place the mouse on its stomach. Make a skin incision (8-10 mm in length) on the dorsal midline from the base of the skull to the interscapular region (Fig. 2a) . Use scissors to separate the skin from the underlying muscle tissue around the incision site and extending toward the left flank; this will create a subcutaneous tunnel.
13|
Position the mouse on its back. Make a skin incision (8-10 mm) on the abdominal midline from the xiphoid cartilage extending to the midabdomen (Fig. 2b) . Use scissors to separate the skin from the underlying muscle tissue. This separation process will move toward the left flank to complete a connection with the subcutaneous tunnel created from the neck.
14|
Position the mouse on its right side. Insert a curved hemostat from the abdominal skin incision into the subcutaneous tunnel and out of the dorsal neck incision (Fig. 2c) . By using the hemostat, gently grasp the catheter above the Dacron disc (Fig. 2d) . Carefully pull the catheter tip through the subcutaneous tunnel out of the abdominal incision (Fig. 2e) .  crItIcal step Do not grasp the Dacron disc. The integrity of the disc and its adhesion to the tubing may be compromised. 16| Insert a pointed curved hemostat into the abdomen, place the tip against the inner abdominal wall at the site ~20 mm toward the left flank from the incision, and then make a hole in the abdominal wall by pressuring the tip and penetrating the wall (use a scalpel tip to assist if needed). By using the hemostat, grasp and pull the catheter tip into the abdomen (Fig. 2g,h ).
17| Use a curved forceps to find the forestomach by flipping the left liver lobe. Be careful not to damage the liver or any other major organs. The forestomach can be distinguished from the glandular portion of the stomach, as it is whiter in color. Gently grasp the forestomach and pull it out of the incision site (Fig. 2i) . ! cautIon Be careful not to pinch and damage blood vessels on the forestomach. Place the stomach on gauze soaked with saline.
18| Use a jeweler′s forceps to make a small puncture hole (a size of the diameter of Silastic tube) through the forestomach wall in the middle of the forestomach where there is minimal vasculature. Insert the catheter tip into forestomach. With curved forceps, hold the catheter in place (Fig. 2j) . Use saline to prevent dehydration of the exposed stomach. Catheter tip placement and subsequent suturing are relatively easier in the morning when the mouse stomach is still full of diet consumed the previous night. As gastric emptying becomes more complete in the afternoon, gastric liquid content tends to spill out of the puncture site. Try to block and absorb this with gauze.
19| Use 6/0 silk or other nonabsorbable suture material to stitch the Dacron disc to the forestomach wall. Four to six stitches around the disc perimeter will secure its placement (Fig. 2k) . After completing the suturing, gently infuse ~0.1 ml saline into the stomach using the saline-filled syringe attached to the proximal end of the catheter. Ensure that there is no leakage from the sutured disc.
20|
Replace the whole stomach to the original resting position by pushing it into the abdomen while gently pulling the catheter from the dorsal neck side. The Dacron disc should be placed against the abdominal hole in the left flank. ! cautIon Ensure that the spleen and a splenic portion of pancreas are not trapped by the disc.
21|
Close the peritoneal cavity using 6/0 silk or absorbable suture and a continuous suture pattern (Fig. 2l) . ! cautIon Be careful not to puncture the internal organs, including abdominal fat.
22|
Close the abdominal skin incision using 6/0 silk or other nonabsorbable suture and an interrupted suture pattern (Fig. 2m) .
23| Position the mouse on its stomach. Position the anchoring Dacron along the dorsal neck muscle (Fig. 2n ).
24| Use 6/0 silk to suture the Dacron onto the neck muscle by placing two stitches on either side (Fig. 2o) . ! cautIon This suture is crucial to firmly anchor the catheter entry site. Ensure that you stitch a sufficiently deep layer of the muscle to achieve this. 
25|
Close the dorsal neck skin incision using 6/0 silk and a simple interrupted suture pattern (Fig. 2p) .
26|
For recovery, place the mouse in a shoe-box cage warmed by a heating pad. Connect the catheter to a swivel and connect a 1-ml syringe filled with saline to the swivel with Tygon tubing (i.d. 0.508 mm, 50 mm in length). Suspend the catheter by clamping the swivel above the cage. Inject Buprenex (0.025 mg kg − 1 ) as an analgesic subcutaneously when the mouse begins to recover from anesthesia. For hydration, warm lactated Ringer′s solution can be administered subcutaneously (1 ml per mouse).
27|
Cut the Nylon tubing to 50 mm in length and use it to cover the catheter above the neck. This will protect the catheter from being chewed by the mouse.
animal housing and infusion setup • tIMInG 4-6 d (including recovery) 28|
Leave the mouse to recover from anesthesia in a cage placed on a heating pad. Once the mouse has recovered from anesthesia, remove the cage from the heating pad and place it on a stainless steel rack (Fig. 3) . Attach a rod with clamps to the rack to support the swivels above cages. Keep a 1-ml syringe connected to the swivel for 2 d after surgery until dietary infusion begins. During the 2-d postoperative period, provide water and regular chow.
29|
On the second day after surgery, remove chow from the cage (from this stage onward, a basic liquid diet will be infused for a recovery period of 4-6 d, set up as described in the following steps). . 3b ).
33|
Once all three ends of the Y-shaped connector are connected with appropriate tubing, fill the dead space of the lines with saline to ensure that there is no air.  crItIcal step The solutions should be added in the precise sequence shown in the table, one at a time, to avoid precipitation. Thereafter, dissolve the trace mineral mix. 5. Turn off the heat and let it cool down to body temperature, and then dissolve vitamin and choline chloride (solution B). Place it in a refrigerator.  pause poInt Solutions A and B (table 1) can be stored at 4 °C overnight. 6. Take solution B out of the refrigerator and ensure that there is no precipitation at the bottom of the beaker. Warm the solution to room temperature under constant stirring. 7. Measure solution A and divide it into two equal volumes by using a 2-liter graduated cylinder. 8. Measure the volume of solution B and divide into two equal volumes by using a 1-liter graduated cylinder. As you measure solution B, filter it using a 70-µm Spectra Nylon mesh. 9. Measure 193.2 g of Mazola corn oil (for high-fat diet) and 8.5 g of xanthan gum (for high-fat diet). . 3b ) via 20-G Intramedic Luer stub adaptors ('e' in Fig. 3b ).
35|
Infuse the basic diet (table 1; box 1) and dextrose (9.4% (wt/vol)) for a 4-to 6-d recovery period (Fig. 3c) . ! cautIon Pumps may generate heat, which can promote air bubble formation within diet syringes.  crItIcal step Disposable diet syringes may need to be changed, as this type of syringe plunger tends to lose lubrication and does not allow smooth infusion.  crItIcal step Transfer a frozen aliquot of diet from a − 20 °C freezer to a refrigerator 24 h before feeding in order to allow slow thawing. Thaw out just enough diet for each day so that freshly thawed diet is always fed.  crItIcal step The liquid diet described below contains no preservatives. For this reason, only freshly thawed diet should be used. ? troublesHootInG ethanol feeding • tIMInG ~2 min per mouse 36| For ethanol feeding experiments, prepare diluted ethanol solution using 95% (vol/vol) ethanol in advance to achieve incrementally increasing doses as shown in table 2. ! cautIon As 100% ethanol absorbs water from air, 95% (vol/vol) solution should be prepared immediately upon opening a new container of 100% ethanol.
37|
Start infusing ethanol using a 10-ml syringe filled with an appropriate concentration of ethanol as detailed in table 2 and the Harvard Apparatus infusion pump (Model PHD) set at an infusion rate of 8 ml per 20 g body weight per day.
38| As a control for ethanol feeding, start infusing isocaloric dextrose solution using the concentrations listed in table 2.
animal monitoring • tIMInG ~1 min per mouse 39| Monitor the condition of each mouse daily to assess the catheter, the catheter exit site at the dorsal neck, the general physical appearance and activity, and the presence of feces and urine in the cage. Check the mouse′s body weight daily or weekly by disconnecting the infusion lines from the swivel and weighing the mouse with the catheter and the swivel. The weight of the latter can be subtracted to record the mouse′s body weight.
? troublesHootInG 40| For ethanol infusion experiments, measure the degree of intoxication at least three times a day (morning, early and late afternoon). The dosages and schedule shown in table 2 should achieve sufficient ethanol intake and blood alcohol levels (BALs) while minimizing the risk of overintoxication. However, during the third and fourth week of observations, one may observe individual variations in the response to ethanol dosing, thereby necessitating adjustments on an individual basis. The guideline described in box 2 is helpful in the assessment of intoxication and implementation of individual adjustments. 
41|
Flush the catheter daily with saline when changing the diet. Cleaning of the catheter with a stainless steel wire may be performed especially when a diet with high viscosity is used. This will help prevent catheter clogging. ? troublesHootInG.
? troublesHootInG Troubleshooting advice can be found in table 3.
Box 2 | Intoxication degree and recovering procedure
Degree 0: Upon touching and pulling the tail, the animal swiftly tries to escape and assumes a defensive position toward you.
Degree + 1: The animal is slightly slow to respond with slightly diminished motor coordination in the lower extremities. One may smell alcohol in the animal's cage. One may observe the animal without removing ethanol from the syringe; alternatively, remove 0.2-0.4 ml of ethanol if the intoxication is thought to be getting worse.
Degree + 2: Motor coordination of the lower body is obviously impaired, but the animal can still move around in the cage. The animal may run from side to side instead of a straight direction. Remove 0.4-0.6 ml of ethanol only.
Degree + 3: The animal moves only its head and forelegs while the rest of the body is immobilized. Remove 0.6 ml-0.8 ml of ethanol only or stop the pump for a short period until the animal begins to lift its own body weight and move around slowly.
Degree + 4: Anesthetic stage accompanied by a loss of whole body motor coordination. ! cautIon Stop the infusion pump for both diet and ethanol immediately, and remove the gastric content by aspiration via the catheter using a 1-ml syringe. Subcutaneously inject warm saline (~0.3 ml) every hour until the animal recovers to the + 2 or + 1 degree of intoxication. Thereafter, diet infusion can be resumed, followed by restarting ethanol infusion 1-2 h later.  crItIcal Check the animal's body temperature. Place the cage on a heating pad to prevent hypothermia. After recovery, frequent monitoring is needed as the animal may undergo withdrawal if its BAL drops rapidly in a short time period.
Degree − 1: Withdrawal stage. The animal is jumpy, with paws digging into bedding, body shaking and/or a raised tail. The animal will be sensitive to noise, which may trigger a seizure. Slowly infuse 0.2-0.6 ml of ethanol solution directly through the catheter using a 1-ml syringe. This step may be repeated with 30-to 40-min intervals until physical signs of withdrawal disappear. 
antIcIpateD results
Anticipated results will obviously differ according to how the iG mouse model is used. As an example, we will discuss below anticipated results from the iG mouse model for 1-4 weeks of infusion of high-fat diet and ethanol. table 4 summarizes key outcome parameters for liver damage: liver weight/body weight ratio as a measure of hepatomegaly; plasma ALT levels for a parameter of liver damage; and BALs. These parameters were determined at the end points. As shown, average BALs range from 300 to 350 mg dl − 1 . With these levels of BAL, the animals' intoxication signs are usually rated from 0 to + 1 according to the guidelines discussed above (see box 2). Intoxication of + 2 or + 3 reflects a BAL of above 350 and 450 mg dl − 1 , respectively. Thus, the degree of intoxication achieved in the iG model is substantially greater than that achieved in other models with ad libitum consumption of alcohol-containing diet or water (BALs in these models range from 100 to 200 mg dl − 1 at the utmost). Plasma ALT levels are quickly raised to the average values of 160 and 192 U l − 1 after 1 and 2 weeks of alcohol infusion, and they reach 260-270 U l − 1 at 3-4 weeks. These changes are closely associated with hepatomegaly, which is already evident at 1 week and becomes quite conspicuous at 4 weeks. The mortality rate of this model at 4 weeks is <10%. 
